• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ARUXF:US

1.0100 USD 0.0550 5.76%

As of 20:10:01 ET on 12/01/2014.

Snapshot for Acrux Ltd (ARUXF)

Open: 1.0100 Day's Range: 1.0100 - 1.0100 Volume: 2,000
Previous Close: 0.9550 52wk Range: 0.7500 - 2.2482 1-Yr Rtn: -

Stock Chart for ARUXF

No chart data available.
  • ARUXF:US 1.0100
  • 1D
  • 1M
  • 1Y
0.9550
Interactive ARUXF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARUXF

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 14.8113
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) 0.0840
Est. PEG Ratio -
Market Cap (M USD) 168.19
Shares Outstanding (M) 166.52
30 Day Average Volume 167
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 10.38%
Cash Dividend (AUD) 0.0800
Dividend Ex-Date 09/04/2014
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARUXF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ARUXF

Acrux Limited is a specialty pharmaceutical company that develops a range of healthcare products for the global market. The Company develops transdermal drug delivery systems. The Company's products include hormone products for women's health, anti-aging skin care and haircare products as well as veterinary pharmaceutical products. The company is a Pooled Development Fund.

Ross DobinsonFounderMichael John KotsanisCEO/Managing Director
Sharon PapworthCFO/SecretaryNina WebsterDirector:Commercial
More Company Profile & Key Executives for ARUXF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil